Cargando…
Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than two million deaths. Underlying diseases, including cancer, are high-risk factors for severe COVID-19 outcomes. Angiotensin-converting enzyme 2 (ACE2), as...
Autor principal: | Wang, Xiao-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953344/ https://www.ncbi.nlm.nih.gov/pubmed/33738043 http://dx.doi.org/10.4251/wjgo.v13.i3.157 |
Ejemplares similares
-
Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022) -
Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
por: Ferreira, Anderson J., et al.
Publicado: (2012) -
The role of angiotensin-converting enzyme 2 (ACE2) receptor in the intestine in COVID-19: more research needed
por: Leung, Char, et al.
Publicado: (2020) -
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020) -
Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023)